SK

Sravanthi Kosimala

Director Director DIN 08684614
DIN 08684614 First appointment Jan 2020 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 2020
Shareholding value Locked Premium profile

About Sravanthi Kosimala

Data last updated:

Sravanthi Kosimala has 6 years in corporate governance. Formerly with 1 company, such as Basilic Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08684614
Primary Designation Director
First Appointment 30 Jan 2020
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director30 Jan 20202020Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Basilic Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sravanthi Kosimala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sravanthi Kosimala

Sravanthi Kosimala has 6 years in corporate governance. Formerly with 1 company, such as Basilic Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Sravanthi Kosimala is associated with 0 companies as a director.

Sravanthi Kosimala has expertise in General Business.

Sravanthi Kosimala has 6 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available